A Phase 1/2 Study of Oral 5-Azacitidine and Romidepsin in Patients with Lymphoid Malignancies Reveals Promising Activity in Heavily Pretreated Peripheral T-Cell Lymphoma (PTCL)
暂无分享,去创建一个
C. Deng | O. O’Connor | L. Falchi | J. Amengual | E. Marchi | A. Sawas | K. Khan | J. Lue | Hye A. Kim | Laine E. Atkins | E. Lichtenstein | C. Rojas | A. Rada | Cremers Serge | L. Atkins